Semi-Annual Consolidated Statement Of Income

Daito Pharmaceutical Co., Ltd. - Filing #7712791

Concept 2018-06-01 to
2019-02-28
2017-06-01 to
2018-02-28
Semi-annual consolidated statement of income
Statement of income
Net sales
30,401,398,000 JPY
29,636,902,000 JPY
Cost of sales
23,746,489,000 JPY
23,462,245,000 JPY
Gross profit (loss)
6,654,909,000 JPY
6,174,656,000 JPY
Ordinary profit (loss)
3,753,009,000 JPY
3,245,387,000 JPY
Selling, general and administrative expenses
Selling, general and administrative expenses
2,990,617,000 JPY
2,991,140,000 JPY
Extraordinary income
194,928,000 JPY
20,524,000 JPY
Extraordinary losses
184,092,000 JPY
525,000 JPY
Operating profit (loss)
3,665,617,000 JPY
3,185,330,000 JPY
Profit (loss) before income taxes
3,763,845,000 JPY
3,265,386,000 JPY
Non-operating income
Interest income
871,000 JPY
681,000 JPY
Dividend income
68,021,000 JPY
62,916,000 JPY
Non-operating income
111,591,000 JPY
95,008,000 JPY
Non-operating expenses
Interest expenses
15,688,000 JPY
18,208,000 JPY
Non-operating expenses
24,199,000 JPY
34,951,000 JPY
Income taxes
1,224,776,000 JPY
985,177,000 JPY
Profit (loss)
2,539,069,000 JPY
2,280,208,000 JPY
Extraordinary income
Profit (loss) attributable to non-controlling interests
-11,391,000 JPY
-20,036,000 JPY
Extraordinary losses
Profit (loss) attributable to owners of parent
2,550,460,000 JPY
2,300,244,000 JPY
Other comprehensive income
Valuation difference on available-for-sale securities
-42,259,000 JPY
156,266,000 JPY
Foreign currency translation adjustment
-63,589,000 JPY
90,938,000 JPY
Remeasurements of defined benefit plans, net of tax
6,081,000 JPY
3,186,000 JPY
Other comprehensive income
-99,767,000 JPY
250,391,000 JPY
Comprehensive income
2,439,301,000 JPY
2,530,599,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
2,469,977,000 JPY
2,523,019,000 JPY
Comprehensive income attributable to non-controlling interests
-30,676,000 JPY
7,580,000 JPY
Profit attributable to

Talk to a Data Expert

Have a question? We'll get back to you promptly.